Piper Sandler Q1 Record Revenues Led by DCM Advisory and Healthcare ECM Gains
Piper Sandler posted record Q1 revenues, with its Debt Capital Markets advisory business delivering its strongest quarter and equity capital markets market share surging, particularly in healthcare. Bank M&A larger-deal volume slowed more than anticipated, but its derivative desk saw increased hedging transactions driven by heightened rate volatility.
1. Record Q1 Revenues Surge
Piper Sandler achieved record revenues in Q1 2026, driven by an exceptional performance in its Debt Capital Markets advisory business, which reported its strongest quarter to date. The firm also captured outsized market share in equity capital markets, notably in the healthcare sector, through several large fee transactions.
2. Bank M&A and Derivative Desk Activity
While announced bank M&A volume in larger deals slowed more than anticipated, Piper Sandler completed a number of smaller transactions and expanded its pipeline. Its derivative desk experienced heightened activity, executing increased hedging trades driven by volatile forward rate curves from interest rate fluctuations.
3. Advisory Outlook and Sector Trends
Advisory fee revenue is projected to be down sequentially, reflecting a choppy macro environment and uneven sponsor deal launches. Sectors such as healthcare and MedTech saw a spectacular Q1, but technology M&A is expected to moderate as valuations decline and corporates adopt caution over AI-driven disruptions.
4. Non-M&A Businesses Strength
Non-M&A divisions performed well, with Debt Capital Markets advisory delivering an outsized performance and private capital advisory gaining steam after recent acquisitions. Restructuring activity remained relatively active, supporting diversified revenue streams as M&A slowed.